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Abstract 
The effect of azido-phthalonate, a photoreactive analogue of oxoglutarate, on the transport of oxoglutarate was investigated in 
proteoliposomes reconstituted with the purified oxoglutarate carrier. In the dark, azido-phthalonate inhibits the reconstituted oxogluta- 
rate/oxoglutarate exchange in a competitive manner with a K i of 0.38 mM. Upon photoirradiation, the inhibition of the oxoglutarate 
exchange by azido-phthalonate is not removed by passing the proteoliposomes through a Sephadex column. The light-induced inhibition 
of the oxoglutarate/oxoglutarate exchange activity by azido-phthalonate is time- and concentration-dependent. The kinetic analysis of 
transport inhibition by azido-phthalonate reveals that one molecule of this substrate analogue bound to the functional carrier molecule is 
responsible for complete inhibition of the carrier function. Azido-[3H]phthalonate binds to the oxoglutarate carrier covalently. Incubation 
of the proteoliposomes with oxoglutarate during photoirradiation i the presence of azido-phthalonate protects the carrier against 
inactivation and decreases the amount of radioactivity which is found to be associated with the carrier protein. It is concluded that 
azido-phthalonate can be used for photoaffinity labeling of the mitochondrial oxoglutarate carrier at the substrate-binding site. 
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I. Introduction 
The inner mitochondrial membrane contains a specific 
carrier system that catalyzes a counterexchange between 
oxoglutarate and malate (for review, see Refs. [1] and [2]). 
The oxoglutarate carrier plays an important role in several 
metabolic processes like gluconeogenesis from lactate and 
the malate-aspartate shuttle. In our laboratory the mito- 
chondrial oxoglutarate carrier was isolated from heart and 
liver and functionally reconstituted into liposomes [3,4]. 
Kinetically, the carrier functions according to a simultane- 
ous (sequential) mechanism [5,6]. In  1990, the amino acid 
sequence of the oxoglutarate carrier was determined by 
Abbreviations: SDS, sodium dodecylsulfate; Pipes, 1,4-piperazine- 
diethanesulfonic a id. 
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cDNA sequencing [7]. More recently, the oxoglutarate 
carrier was overexpressed in Escherichia coli and refolded 
in active form [8]. Furthermore, a great deal of information 
on the transmembrane arrangement of this carrier in the 
mitochondrial membrane has been obtained [9]. Although 
there is such a large amount of information regarding the 
functional and structural properties of the oxoglutarate 
carrier no studies have yet been performed towards the 
identification of the substrate-binding sites. 
The substrate-analogue phthalonate is a strong and com- 
petitive inhibitor of the oxoglutarate carrier [10]. With the 
aim of labeling the substrate-binding site of the oxogluta- 
rate carrier, we synthesized azido-phthalonate and investi- 
gated its effects on the purified oxoglutarate carrier recon- 
stituted into liposomes. Our results show that azido- 
phthalonate binds to the oxoglutarate carrier covalently 
upon photoirradiation and one molecule of azido- 
phthalonate modifies one molecule of the functional carrier 
unit. 
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2. Materials and methods 
2.1. Materials 
Hydroxyapatite (Bio-Gel HTP), AG1-X4 and AG1-X8 
were purchased from Bio-Rad; Celite 535 from Roth, 
AMPLIFY and 2-keto[5-14C]glutaric a id from Radio- 
chemical Centre (Amersham, UK); Pipes and Triton X-114 
from Sigma; pyridoxal 5'-phosphate from Serva; 5-amino- 
tetralin and Amberlite XAD-2 from Fluka; egg yolk phos- 
pholipids from Merck; Sephadex G-75 from Pharmacia. 
All other reagents and solvents were of the highest purity 
commercially available. 
2.2. Isolation and reconstitution of the oxoglutarate car- 
rier 
The oxoglutarate carrier from bovine heart mito- 
chondria was purified in Triton X-114 by the procedure 
introduced by Bisaccia et al. [3]. Reconstitution of the 
carrier into liposomes was performed by removing the 
detergent with a hydrophobic on-exchange column [6,11]. 
The composition of the starting mixture used for reconsti- 
tution was: 200 /~1 of the purified protein (hydroxy- 
apatite/celite eluate, about 2 /zg), 100 /zl of 10% egg 
yolk phospholipids in the form of sonicated liposomes 
prepared as described in Ref. [3], 10 mM oxoglutarate and 
10 mM Pipes, pH 7, in a final volume of 700 /xl. After 
vortexing, this mixture was passed 15 times through the 
same Amberlite column (0.5 x 2.5 cm), preequilibrated 
with a buffer containing 10 mM Pipes, pH 7. All the 
operations were performed at 4 ° C, except the passages 
through Amberlite that were performed at room tempera- 
ture. The external substrate was removed by passing 600 
/zl proteoliposomes through a Sephadex G-75 column 
(0.7 x 15 cm) preequilibrated with 50 mM NaCI and 10 
mM Pipes, pH 7. 
2.3. Transport measurements 
The first 600/xl of the turbid eluate from the Sephadex 
column were collected, transferred to reaction vessels (150 
/zl each), incubated at 25°C for 4 min and then used for 
transport measurements by the inhibitor stop method [12]. 
Transport was initiated by adding 0.1 mM [14C]oxogluta- 
rate and stopped, 1 min later, by adding 10 mM pyridoxal 
5'-phosphate. In control samples, the inhibitor was added 
together with the labeled substrate. The assay temperature 
was 25 ° C. Finally, the external radioactivity was removed 
by an anion-exchange column (AG1-'X8, 100-200 mesh, 
acetate form, 0.5 X 4 cm). The liposomes eluted with 1 ml 
of 50 mM NaCI were collected in a 4 ml scintillation 
mixture, vortexed and counted. The transport activity was 
calculated by subtracting the control from the experimental 
values. In all the experiments he oxoglutarate/oxogluta- 
rate exchange activity in the samples without inhibitor 
varied from 3200 to 4350 /xmol/min per g protein. 
2.4. Synthesis and purification of azido-phthalonic acid 
The precursor of azido-phthalonic a id, 5-azido-tetralin 
(2 of Fig. 1), was synthesized from amino-tetralin (1 of 
Fig. 1) according to Heilbrun et al. [13] with a yield of 
75%. The purity of 5-azido-tetralin was verified by TLC 
eluted with ethyl acetate/n-hexane (30:70, v/v;  R F = 
0.85) and the characteristic absorption IR band at 2933 
cm-1 confirmed the presence of an azido group. For the 
synthesis of azido-phthalonic a id (3 of Fig. 1), 17 ml of 
0.89 M KMnO 4 were added dropwise, at room tempera- 
ture, in 1.5 h to a solution of 500 mg of 5-azido-tetralin 
suspended in 5 ml of 0.5 M NaOH. The mixture was 
stirred for 30 min and the temperature action was then 
increased and maintained constant at 75°C for 1 h. The 
reaction was monitored by SiO 2 TLC eluted by n- 
butanol/water/acetic acid (60:25:15 v/v).  The MnO 2 
was then filtered and the solution was acidified at pH 1 
with H2SO 4 and extracted with ethyl acetate (three times 
10 ml). The organic phases were pooled, dried on NazSO 4 
and, after removal of the solvent at reduced pressure, 292 
mg of the crude product was obtained with R F = 0.4 in the 
above solvent system. The preliminary step of purification 
was performed by an AG1-X4 column (200-400 mesh, 
1.5 x 15 cm), eluted with formic acid 15 M [14]. Azido- 
phthalonic acid (180 mg, yield 27%) was obtained as white 
amorphous solid by preparative TLC eluted with n- 
butanol/water/acetic acid (60:25:15, v/v).  The purity of 
the product was checked by TLC on silica gel F254 (Merck). 
The molecular structure was confirmed by 13C-NMR, 1H- 
NMR, IR and MS. 
2.5. Synthesis of azido-[3H]phthalonic acid 
102 mg of azido-phthalonic a id were dissolved in 1 ml 
of dimethylformamide using 102 mg of 5% Rh/A1203 as 
catalyst. 25 Ci of tritiated water were added to this solu- 
tion. The reaction was stirred for 12 h at room tempera- 
ture. Labiles were removed with methanol. The specific 
activity was 1.87 GBq/mmol. Azido-[3H]phthalonic a id 
was obtained from the Tritium Labeling Service (Du Pont). 
2.6. Covalent modification of the oxoglutarate carrier 
Proteoliposomes (2 ml) were photoirradiated in the 
3 presence of azido-phthalonate or azido-[ H]phthalonate 
(specific radioactivity 50.7 mCi/mmol) at 0 ° C for 20 min 
NH 2 X- +N s 
H,H 2 NaN, ~ KNn04._~,~i~COC00H 
l -  +N s 
! Z s_ 
Fig. 1. Synthesis of azido-phthalonic acid. 
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(unless otherwise indicated). Photoirradiation was carried 
out with a 250 W Osram Halogen lamp at 0°C under 
shaking and in quartz tubes. The modification reaction was 
stopped by switching off 1:he light and rapidly passing the 
liposomes through a Sephadex G-75 column preequi- 
librated with 50 mM NaCI and 10 mM Pipes, pH 7. 
2.7. Other methods 
In order to extract the oxoglutarate carrier from the 
proteoliposomes, the photoirradiated proteoliposomes (7.5 
ml) were precipitated with cold acetone and the lipids were 
carefully removed as described in Ref. [9]. Polyacrylamide 
slab-gel electrophoresis was performed in the presence of 
0.1% SDS according to Laemmli [15]. The stacking gel 
contained 5% acrylamide and the separation gel contained 
17.5% acrylamide and an acrylamide/bisacrylamide ratio 
of 150. Staining was performed with Coomassie brilliant 
blue. For fluorographic detection of radioactivity, the 
stained gels were treated with AMPLIFY for 30 min and 
dried on filter paper in vacuo (70 ° C, 90 min). The fluoro- 
graphic exposure of a non pre-flashed X-ray film (Kodak 
X-OMAT) took 4-6 weeks at - 80 ° C. Protein was deter- 
mined by the Lowry method modified for the presence of 
Triton [16]. 
1H-NMR and 13C-NMR spectra were recorded at 30°C 
on a Bruker AM400. 13C-NMR spectra were performed at 
100.5 MHz using the products dissolved in CD3OD. The 
IR spectra were performed by Perkin Elmer 399; the low 
resolution electronic mass spectrometry data were obtained 
using a TRIO 2000 Fisons at 70 eV, 400/zA and a source 
temperature of 200 ° C. 
3.2. Inhibition of the reconstituted oxoglutarate carrier by 
azido-phthalonate without illumination 
The effect of the newly synthesized compound azido- 
phthalonate on the transport of oxoglutarate in proteo- 
liposomes without irradiation is shown in Fig. 2 as a 
Lineweaver-Burk plot. Azido-phthalonate inhibited the re- 
constituted oxoglutarate/oxoglutarate exchange activity in 
proteoliposomes in a competitive manner with respect o 
the substrate. From this and other experiments a K i of 
0.38 + 0.03 mM (in five determinations) was estimated. 
3.3. Inhibition of the reconstituted oxoglutarate carrier by 
azido-phthalonate upon illumination 
It is known that azido compounds photolyse on expo- 
sure to ultraviolet light to form a highly reactive nitrene. 
This nitrene is able to react covalently with its environ- 
ment [17]. In the following experiments the effect of 
azido-phthalonate on the reconstituted oxoglutarate carrier 
activity was investigated upon photoirradiation. Fig. 3A 
illustrates the dependence of the light-induced azido- 
phthalonate inhibition of the reconstituted oxogluta- 
rate/oxoglutarate exchange on the concentration of the 
inhibitor. In this experiment proteoliposomes were illumi- 
nated in the presence of azido-phthalonate. After removal 
of the unbound azido-phthalonate by gel filtration, the 
reconstituted oxoglutarate/oxoglutarate exchange activity 
was measured. The results show that the inhibition of the 
oxoglutarate carrier activity increased with increasing con- 
centrations of azido-phthalonate with an IC50 of 0.4 mM. 
As a control, Fig. 3A shows that the activity of the 
3. Results 
3.1. Synthesis of azido-phthalonic a id 
The oxidation reaction of 5-azido-tetralin had to be 
performed at basic pH so as to lower the oxidation power 
of KMnO 4. Moreover, the temperature action had to be 
held at 75 ° C; above this temperature the yield of azido- 
phthalonic acid decreased while azido-phthalic acid began 
to form. The identity of azido-phthalonic acid was con- 
firmed by means of spectroscopic methods. A character- 
istic absorption band at 3000 cm-a of the azido group was 
present in IR (Nujol) spectrum. Moreover, 13C-NMR (D20) 
spectrum showed the following chemical shifts: 3:190.97 
(Ph-C--O), 174.41 (Ph-COOH) and 165.80 (Ph-CO- 
COO--H); the 1H-NMR spectrum was also in agreement 
with the proposed structure. The MS spectrum recorded 
showed the ion molecula.r peak at m/z  235 (M+), the 
molecular peak with loss of CO 2 at m/z  191 and an ion 
peak at m/z  177 produced by loss of CO 2 and nitrogen. 
! 
v 
0.50 
0.25 
I I I f 
0 2.5 5 7.5 ! 0 
I /  [OXOGLUTARATF] (ram -'m) 
Fig. 2. Competitive inhibition of oxoglutarate transport by azido- 
phthalonate in the dark. The proteoliposomes w re incubated for 1 min at 
25 ° C in the dark with the indicated concentrations f [ 14 C]oxoglutarate in 
the absence (C)) or in the presence of 0.35 mM (0) or 0.7 mM (A) 
azido-phthalonate. V isexpressed in p, mol/min per mg protein. 
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Fig. 3. (A) Dependence of the inhibition of the reconstituted oxoglutarate carrier activity on azido-phthalonate concentration i the dark and upon 
irradiation. The proteoliposomes were incubated for 20 min at 0 ° C with the indicated concentrations of azido-phthalonate with (0 )  or without (O)  
irradiation. After a second gel filtration to remove the unbound inhibitor, the oxoglutarate/oxoglutarate exchange was measured. (B) Dependence of the 
inhibition of the reconstituted oxoglutarate carrier activity by azido-phthalonate on the photoirradiation time. The proteoliposomes were irradiated for the 
times indicated at 0 ° C in the presence (0 )  or absence (©) of 2 mM azido-phthalonate. After a second gel filtration to remove the unbound inhibitor, the 
oxoglutarate/oxoglutarate exchange was measured. 
oxoglutarate carrier was not influenced by azido- 
phthalonate without photoirradiation, in agreement with 
the finding that the inhibition by azido-phthalonate in the 
dark is reversible (Fig. 2). The effect of the photoirradia- 
tion time on the oxoglutarate transport activity in the 
presence and absence of 2 mM azido-phthalonate is shown 
in Fig. 3B. It can be seen that photoirradiation of the 
proteoliposomes alone, i.e., in the absence of azido- 
phthalonate, caused a slight inhibition of oxoglutarate 
transport, which reaches a value of 30% after 30 min of 
illumination. For this reason in all the other experiments 
the proteoliposomes were illuminated for 20 min and the 
inactivation caused by this treatment was always sub- 
tracted from the inhibition values obtained in the presence 
of azido-phthalonate. Fig. 4A shows the semilogarithmic 
plots of the remaining activity with azido-phthalonate ver- 
sus time. The data fitted straight-lines, the slope of which 
allowed one to calculate apparent first-order rate constants 
of the inactivation reaction (with respect to the protein) for 
different inhibitor concentrations [18]. From the slope of 
double-logarithmic plot (Fig. 4B) the reaction order with 
respect o azido-phthalonate could be determined to be 
n = 0.71 + 0.056. This value suggests that the reaction of 
one molecule of azido-phthalonate p r functional carrier 
molecule lead to complete inhibition of the carrier func- 
tion. 
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Fig. 4. Kinetics of inactivation of the reconstituted oxoglutarate carrier by azido-phthalonate. The proteoliposomes were illuminated at 0 ° C in the presence 
of different concentrations of azido-phthalonate (0 ,  0.05 mM; O, 0.1 mM; A, 0.25 mM; r,, 0.5 mM; It, 0.75 mM) for the indicated times. The 
modification reaction was stopped by switching off the light and rapidly passing the proteoliposomes through a Sephadex G-75 column. Then the residual 
activity was measured, which is given as percentage of controls (A). In (A) the means of four experiments are reported. In (B) the double-logarithmic 
secondary plot of the means ___ S.D. of the apparent inactivation constant Kap p (2.3 × slope of the straight lines of A) versus the applied azido-phthalonate 
concentration is shown. 
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Fig. 5. Substrate protection against inactivation by azido-phthalonate. The 
proteoliposomes were irradiated for 20 rain at 0 ° C in the presence of 0.4 
mM azido-phthalonate and the indicated concentrations of oxoglutarate 
(©) or glutarate (0) .  After a second gel filtration to remove the unbound 
inhibitor the residual activity was measured. 
On the basis of the competition experiments it can be 
assumed that azido-phthalonate binds to the oxoglutarate 
carrier at the substrate binding-site. Therefore, it was 
important o test whether oxoglutarate correspondingly 
protects the oxoglutarate carrier from inactivation by 
azido-phthalonate. Fig. 5 shows that the light-induced inhi- 
bition of the oxoglutarate transport activity by 0.4 mM 
azido-phthalonate was progressively reversed by the pres- 
ence of increasing concentrations of oxoglutarate during 
photoirradiation. The specificity of the protection of the 
oxoglutarate carrier against azido-phthalonate inactivation 
was investigated by testing the effect of several anions. As 
shown in Fig. 5, glutarate up to 10 mM had no protective 
effect. Similarly, ADP, phosphate and oxoadipate had 
virtually no effect on the, light-induced inhibition of the 
oxoglutarate carrier by az:ido-phthalonate (not shown). 
3.4. Labeling of the oxoglutarate carrier by azido- 
[ 3 H]phthalonate 
In the experiment illustrated in Fig. 6 the oxoglutarate 
carrier extracted from the proteoliposomes photoirradiated 
in the presence of 1 mM azido-[3H]phthalonate was sub- 
jected to SDS-polyacrylamide g lelectrophoresis and fluo- 
rography. Lane 2 of Fig. 6B shows that azido- 
[3H]phthalonate bound to the purified oxoglutarate carrier 
which corresponds to a band of an apparent molecular 
mass of 31.5 kDa (lanes 1-4 of Fig. 6A and Ref. [3]). As 
shown by lane 3 of Fig. 6B the labeling of the oxoglutarate 
carrier by azido-[3H]phthalonate was drastically reduced 
when oxoglutarate was present during the incubation of the 
proteoliposomes with the inhibitor in the light. In contrast, 
the labeling of the carrier protein was not significantly 
influenced (lane 4 of Fig. 6B) when the proteoliposomes 
were incubated with azido-[3H]phthalonate in the light in 
the presence of glutarate. This agrees with the substrate 
protection of the carrier against inactivation by azido- 
phthalonate (Fig. 5). 
4. Discussion 
The results presented in this paper show that azido- 
phthalonate without illumination inhibits the oxoglutarate 
carrier competitively. Its inhibition constant (K i = 0.38 
mM) is not significantly different from that exhibited, 
under identical experimental conditions, by phthalonate 
(K i = 0.35 mM), the well known competitive and imper- 
meable inhibitor of the oxoglutarate carrier [10]. As com- 
pared to the affinity of the two substrates for the oxogluta- 
rate carrier, the affinity of the new inhibitor azido- 
phthalonate is slightly lower than that for oxoglutarate and 
definitively higher than that for malate [6]. When the 
A B 
1 2 3 4 1 2 3 4 
31.5 k O a • i ~ i 
Fig. 6. Labeling of the oxoglutarate carrier in proteoliposomes by azido-[3H]phthalonate. Theproteoliposomes (7.5 ml) were incubated for 20 min at 0 ° C 
with 1 mM azido-[3H]phthalonate in the light (lanes 2-4) or in the dark (lane 1), in the absence (lanes 1,2) or in the presence of 5 mM oxoglutarate (lane 
3) or 5 mM glutarate (lane 4). After removal of the unbound azido-phthalonate th  oxoglutarate carrier protein was delipidated and subjected to SDS-gel 
electrophoresis and fiuorography. (A) SDS-polyacrylamide g l electrophoresis; (B) fluorography. 
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proteoliposomes are incubated with azido-phthalonate and 
photoirradiated, the oxoglutarate carrier becomes irre- 
versibly modified, as shown by the irreversible inhibition 
of the carrier activity (Fig. 3A) and by the radioactivity 
associated with the carrier (Fig. 6). Most importantly, 
several experimental observations indicate that azido- 
phthalonate binds to the oxoglutarate carrier at the sub- 
strate-binding site. The strongest argument in favour of 
this conclusion is the substrate protection of the oxogluta- 
rate carrier against the inactivation caused by azido- 
phthalonate in the light (Fig. 5) and its binding to the 
carrier protein (Fig. 6). The kinetic analysis of the reconsti- 
tuted oxoglutarate transport inactivation suggests that one 
molecule of azido-phthalonate modifies one molecule of 
the functional carrier unit (Fig. 4). This result could be 
explained by assuming that the oxoglutarate carrier has 
two independent substrate-binding sites, one on the exter- 
nal and the other on the internal side of the membrane (see 
Ref. [6]), and the azido-phthalonate, being impermeable, 
binds only at the external surface. 
In conclusion, we have shown that azido-phthalonate is 
a suitable label to characterize the oxoglutarate-binding 
site of the mitochondrial oxoglutarate carrier. Experiments 
are in progress to identify the region of the oxoglutarate 
carrier modified by azido-phthalonate. 
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